ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $685,000 | -66.8% | 50,000 | -83.3% | 0.02% | -63.1% |
Q4 2014 | $2,061,000 | +27.2% | 300,000 | 0.0% | 0.06% | +71.1% |
Q3 2014 | $1,620,000 | -15.2% | 300,000 | 0.0% | 0.04% | -17.4% |
Q2 2014 | $1,911,000 | +107.7% | 300,000 | +500.0% | 0.05% | +130.0% |
Q3 2013 | $920,000 | -29.9% | 50,000 | -33.3% | 0.02% | -35.5% |
Q2 2013 | $1,312,000 | – | 75,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |